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Abstract
Background: Colorectal cancer is one kind of frequent malignant tumors of the digestive tract which gets high
morbidity and mortality allover the world. Despite the promising clinical results recently, less information is
available regarding the perioperative immunological effects of laparoscopic surgery when compared with the open
surgery. This study aimed to compare the cellular immune responses of patients who underwent laparoscopic(LCR)
and open resections(OCR) for colorectal cancer.
Methods: Between Mar 2009 and Sep 2009, 35 patients with colorectal carcinoma underwent LCR by laparoscopic
surgeon. These patients were compared with 33 cases underwent conventional OCR by colorectal surgeon. Clinical
data about the patients were collected prospectively. Comparison of the operative details and postoperative
outcomes between laparoscopic and open resection was performed. Peripheral venous blood samples from these
68 patients were taken prior to surgery as well as on postoperative days(POD) 1, 4 and 7. Cell counts of total white
blood cells, neutrophils, lymphocyte subpopulations, natural killer(NK) cells as well as CRP were determined by
blood counting instrument, flow cytometry and hematology analyzer.
Results: There was no difference in the age, gender and tumor status between the two groups. The operating
time was a little longer in the laparoscopic group (P > 0.05), but the blood loss was less (P = 0.039). Patients with
laparoscopic resection had earlier return of bowel function and earlier resumption of diet as well as shorter median
hospital stay (P < 0.001). Compared with OCR group, cell numbers of total lymphocytes, CD4+T cells and CD8+T
cells were significant more in LCR group (P < 0.05) on POD 4, while there was no difference in the CD45RO+T or
NK cell numbers between the two groups. Cellular immune responds were similar between the two groups on
POD1 and POD7.
Conclusions: Laparoscopic colorectal resection gets less surgery stress and short-term advantages compared with
open resection. Cellular immune respond appears to be less affected by laparoscopic colorectal resection when
compared with open resection.
Background
Colorectal cancer is one kind of frequent malignant
tumors of the digestive tract which gets high morbidity
and mortality allover the world. Along with peoples’ tran-
sition of life styles and food habits, the incidence rate of
colorectal cancer gets rising for the past few years. Nowa-
days, surgery is still to remain as a principal method to
treat colorectal cancer. Since the first laparoscopic chole-
cystectomy performed in France by Phillippe Mouriat of
Lyons in 1987 [1], the development of minimally invasive
surgery has allowed major changes in the surgical treat-
ment of various benign and malignant diseases, especially
because it limits surgical trauma [2]. During recent years,
the laparoscopic approach has developed as an interest-
ing therapeutic alternative for the resection of various
colorectal diseases [3-6]. In China, The first series of
laparoscopic colorectal resection was reported by Shang-
hai Ruijin Hospital in 1993. Since 2000, there has been a
remarkable increase in this field. Laparoscopic colorectal
surgery has been routinely performed in most of the gen-
eral teaching hospitals [7]. This procedure has been
shown to be feasible in most patients with malignant
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disease and can be performed with faster recovery and
shorter hospitalization than the open approach [8-11].
Despite the promising clinical results, less information
is available regarding the perioperative immunological
effects of laparoscopic surgery when compared with the
open surgery. This prospective clinical study was of
major clinical interest because the reduced surgical
trauma should result in reduced postoperative immune,
especially cellular immune dysfunction in patients under-
going laparoscopic surgery, thus contributing to clinical
and oncologic advantages for these patients.
Until now, it has been reported that the degree of post-
operative inflammatory is reduced after laparoscopic sur-
gery [12,13]. Other groups also observed significantly
better preservation of cell-mediated immunity after
laparoscopic vs open colorectal surgery [14,15]. Further-
more, it has been observed that cell-mediated immunity,
as assessed by delayed-type hypersensitivity testing in
humans, is better preserved after laparoscopic vs open
colorectal resection [16].
Our study was performed to evalute perioperative
immune parameters in 68 patients with colorectal cancer.
We herein analyzed the effects of laparoscopic and open
surgery on proinflammatory C-reative protein(CRP)
levels. Furthermore, we measured lymphocyte subpopula-
tions, leukocyte and neutrophils counts, and circulating
natural killer(NK) cells before surgery and on days1, 4,
and 7 after surgery. This study, therefore, allowed assess-
ment of the effects of laparoscopic and conventional
open colorectal surgery on cellular immune responses
after major abdominal surgery.
Methods
Patients
Between Mar 2009 and Sep 2009, 68 patients diagnosed
with primary colorectal cancer were enrolled into this
study. All patients, who underwent surgical treatment at
Affiliated First People’s Hospital of Shanghai Jiao Tong
University, gave informed consent for the use of blood
samples in this study. Among these prospectively enrolled
patients, 35 underwent laparoscopic colorectal resection
(LCR) and 33 underwent open colorectal resection(OCR).
Patients with colorectal cancer in stage IV intestinal
obstruction, recurrence tumor, preoperative chemoradia-
tion, palliative surgery and perioperative complications
were excluded from the study. Patients with diabetes
mellitus, use of steroids and with other immunological
diseases were excluded from the study as well, since
these events could impair the cellular immune responses
after surgery.
Informed consent was obtained from all patients, who
underwent surgical treatment at Affiliated First People’s
Hospital of Shanghai Jiao Tong University. Our research
have been performed with the approval of the ethics
committee of Affiliated First People’s Hospital of Shang-
hai Jiao Tong University.
Surgery Method
Minimally invasive colorectal surgery was performed as
a laparoscopic-assisted procedure with removal of the
resected specimen via a horizontal minilaparotomy
(5 cm) just above the mons pubis. Laparoscopic surgery
was done using a 5-trocar technique with 1 trocar
(10 mm) inserted via a paraumbilical incision (camera
port). Four additional (5 mm) trocars were inserted in
the right and left lower abdomen. After removal of the
resected specimen and preparation of the stapler anasto-
mosis, we closed the minilaparotomy and reintroduced
pneumoperitoneum.
Conventional colorectal surgery was performed via a
vertical midline incision or a transrectal incision ranging
from 10 to 15 cm above the umbilicus to the mons
pubis. After we removed the resected specimen, we per-
formed a stapler or a handwork anastomosis.
Blood test
Peripheral venous blood samples were taken prior to sur-
gery as well as on postoperative days(POD) 1, 4 and 7.
Leukocyte number, absolute number and percentage of
total lymphocytes for all the investigated patients were
measured using an automated blood cell counter (Beck-
man LH750, America). CRP was measured using a CRP
hematology analyzer (ABX Diagnostics Micros, France).
The parameters of cellular immunity (CD3+, CD4+, CD8+,
CD16+, CD56+ and CD45RO+) were determined by flow
cytometry (Beckman Coulter EpicsXL, America). The
monoclonal antibodies used for immunophentyping were
purchased from Beckman Coulter (France). The samples
were prepared by labeling 50 μL of whole blood with
10 μL of monoclonal antibody for 10 minutes in the dark
using the antibody combinations. Helper T lymphocytes
were determined by UCHT1/13B8.2 indexed for CD3/
CD4. Cytotoxic T lymphocytes were determined by
UCHT1/B9.11 indexed for CD3/CD8. Natural killer cells
were determined by 3G8/N901 indexed for CD16/CD56.
Memory T lymphocytes were determined by UCHL1
indexed for CD45RO.
Statistical analysis
Data were analyzed using SAS9.13 statistical package,
analysis of variance on t test, Wilcoxon rank test and c2
test. Differences were considerd statistically significant
at P < 0.05.
Results
Baseline characteristics
68 patients were enrolled into this study. Among the
35 LCR patients, 20 were male and 15 were female. The
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mean patient age was 68.43 ± 11.16 years in LCR group.
Among the 33 OCR patients, 20 were male and 13 were
female. The mean patient age was 68.33 ± 12.69 years in
OCR group. There was no difference in the age, gender
and tumor status between the two groups (Table 1).
Perioperative complications
Between Mar 2009 and Sep 2009, in our department, 3
patients in LCR group and 2 patients in OCR group suf-
fered from postoperative complications. In LCR group,
anastomotic leakage occurred in 2 patients with low-set
rectal cancer and paralytic ileus occurred in 1 patient
with rectal cancer. All these 3 patients were cured after
expectant treatment. In OCR group, incision disruption
occurred in 1 patient with transverse colonic cancer and
the patient accepted emergent suturation. The other
patient with rectal cancer sufferring from paralytic ileus
was cured after expectant treatment. There was no differ-
ence in postoperative morbidity between the two groups.
Considering cellular immunity impaired by postoperative
complications, which might impact cellular immune out-
comes caused by selection of surgery, we excluded these
5 patients and selected 68 donors into this study at last.
Surgery effects and postoperative recovery
The operating time was a little longer in the laparoscopic
group (P > 0.05), but the blood loss was less (P = 0.039).
Patients with laparoscopic resection had earlier return of
bowel function and earlier resumption of diet as well as
shorter median hospital stay (P < 0.001) (Table 2).
Proinflammatory mediators
After both laparoscopic and open colorectal surgery, we
observed a significant increase of circulating CRP levels
and this increase was similar between the two groups
on POD 1 and POD 4. But on POD 7, CRP descended
to the preoperative level in LCR group, while CRP was
still significantly higher than the preoperative level in
OCR group (Table 3, Figure 1).
Markers of cellular immune responses
Before the operations, there was no difference in the count
of leukocyte, neutrophils, lymphocytes, CD4+T cells, CD8
+T cells, CD45RO+T cells and NK cells between the two
groups. On POD 1, in both two groups, the count of leu-
kocyte and neutrophils significantly rose and the count of
lymphocytes, CD4+T cells, CD8+T cells, CD45RO+T cells
and NK cells significantly descended, while there was no
difference between the two groups. On POD 4, the count
of lymphocytes, CD4+T cells and CD8+T cells were signifi-
cantly higher in LCR group than OCR group. The count
of CD45RO+T cells in LCR group also had significant rise
trend compared with OCR group, while the count of NK
cells in OCR group still had continuous depression trend
Table 1 Baseline characteristics
LCR (n = 35) OCR (n = 33) statistic P value
Gender
Male 20 20 c2 = 0.084 0.772
Female 15 13
Age (yr) 68.43 ± 11.16 68.33 ± 12.69 Z = 0.055 0.956
Height (cm) 165.77 ± 8.23 162.36 ± 7.67 t = 1.760 0.082
Weight (kg) 63.30 ± 10.82 60.98 ± 11.33 Z = -1.032 0.302
BMI (kg/m2) 22.95 ± 2.88 22.91 ± 3.22 t = 0.060 0.956
Tumor position
Left hemicolon 5 2 c2 = 0.002 0.564
Transverse colon 1 2
Right hemicolon 9 13
Sigmoid colon 7 4
Rectum 13 12
Tumor staging of TNM





I 2 0 c2 = -0.083 0.934
II 26 28
III 7 5
The baseline characteristics were similar between the two groups (P > 0.05).
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compared with LCR group. On POD 7, the count of
CD4+T cells, CD8+T cells and CD45RO+T cells rose to
the preoperative levels in LCR group. In OCR group, the
count of CD4+T cells and CD45RO+T cells also rose to
the preoperative levels, while the count of CD8+T cells
was still significantly depressed compared with the preo-
perative level (Table 3, Figure 2, 3, 4, 5 and 6).
Discussion
Colorectal cancer is one kind of frequent malignant
tumors of the digestive tract which gets high morbidity
and mortality all over the world. Nowadays, surgery is still
to remain as a principal method to treat colorectal cancer.
On the other hand, tumor immunity, mainly defined as
the immune responses in the body against tumor, acts an
important role during the process when patients fight
against tomors. When tumor antigens were recognised by
antigen presenting cells(APC), they were processed as pep-
tides, and these peptides presented by APC acted as first
and second signals to activate naive CD4+T cells and
CD8+T cells. As naive CD4+T cells and CD8+T cells
received these signals, they differentiated into Th0 cells
and pCTL. When Th0 cells received different allostimula-
tory signals, they were activated as Th1 and Th2 cells. IL-4
secreted by Th2 cells acted as allostimulatory signal to
activate B cells. Activated B cells could secrete generous
tumor specific antibodies and killed tumor cells through
complement dependent cytotoxicity(CDC) and antibody
dependent cell-mediated cytotoxicity(ADCC). IFN-g
secreted by Th1 cells acted as allostimulatory signal to
activate pCTL. Activated CTL could kill tumor cells
directly. Besides, IFN-g secreted by Th1 cells could
enhance the activity of NK cells and M, which could
fight against tumors through ADCC. After antitumor
immune responses, part of activated T cells could differ-
entiate into memory T cells(CD45RO+T cells), which had
quick reaction against tumor cells in twice antitumor
immune responses [17,18]. It can be seen that cellular
immunity acts an predominant role in tumor immunity.
Although surgery is regarded as the most important way
in tumor therapy, many reports have confirmed that sur-
gery stress has great depressant effect on cellular immu-
nity in the body, which would bring negative influence to
prognosis of patients [16,19,20]. So to think of a way to
decrease surgery stress as well as the influence of cellular
immunity becomes quite important.
The development of minimally invasive surgery has
allowed major changes in the surgical treatment of various
benign and malignant diseases, especially because it limits
surgical trauma. Since Jacobs [21] reported the first case of
laparoscopic sigmoidectomy, during recent years, the
laparoscopic approach has developed as an interesting
therapeutic alternative for the resection of colorectal can-
cer. Because the surgical trauma is limited, the laparo-
scopic approach usually allows for a rapid return to
preoperative activity levels with significantly shorter
hospitalization.
This study found that the operating time of LCR group
and OCR group were 137.29 ± 34.58 min and 130.61 ±
36.72 min, prospectively. There was no difference between
the two groups. Conventional versus laparoscopic assisted
surgery in colorectal cancer (CLASSICC) [22], Colon can-
cer laparoscopic or open resection study group (COLOR)
[6] and Lezoche [8] also observed similar results. Our find-
ings shew that the intraoperative blood loss in LCR group
and OCR group were 117.27 ± 65.21 ml and 159.39 ±
83.40 ml, prospectively. We found the intraoperative
blood loss was much less in LCR group. Barcelona [5] and
COLOR [6] also observed similar outcomes as we did.
Patients with laparoscopic resection had earlier return of
bowel function and earlier resumption of diet as well as
shorter median hospital stay. This observation confirmed
findings reported by Breukink [23]. Our findings suggested
that short-term quality-of-life benefits could be observed
with LCR when compared with OCR.
Besides the promising clinical results, we focused on
the perioperative cellular immunological effects of LCR
when compared with OCR.
Table 2 Surgery effects and postoperative recovery
LCR (n = 35) OCR (n = 33) Z value P value
Operating time (min) 137.29 ± 34.58 130.61 ± 36.72 -0.752 0.452
Blood loss (ml) 117.27 ± 65.21 159.39 ± 83.40 -2.064 0.039*
Enterokinesia (d) 1.86 ± 1.09 3.00 ± 0.92 4.481 <0.001*
Outgas (d) 2.54 ± 1.38 3.78 ± 1.18 4.144 <0.001*
Out-of-bed activity (d) 2.80 ± 1.26 3.38 ± 1.07 2.385 0.017*
Fluid (d) 3.14 ± 1.35 5.27 ± 1.28 5.624 <0.001*
Semifluid (d) 5.47 ± 1.50 7.97 ± 1.31 5.559 <0.001*
Postoperative hospital stay (d) 9.88 ± 4.02 14.06 ± 1.46 5.896 <0.001*
Total hospital stay (d) 17.91 ± 5.71 20.74 ± 2.42 3.740 <0.001*
LCR group had more operating time (P > 0.05) but less blood loss (P < 0.05) than OCR group. Patients with laparoscopic resection had earlier return of bowel
function and earlier resumption of diet as well as shorter median hospital stay (P < 0.05).
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Table 3 Summary of proinflammatory responses and cellular immunity
Immune mediators LCR (n = 35) OCR (n = 33)
Preoperative POD 1 POD 4 POD 7 Preoperatvie POD 1 POD 4 POD 7
WBC (× 109/L) 6.10 ± 1.68 10.88 ± 2.29# 7.60 ± 1.93# 7.28 ± 1.46# 6.07 ± 1.45 12.21 ± 4.10# 8.24 ± 2.52# 7.96 ± 2.34#
Neutrophils (× 109/L) 3.81 ± 1.62 9.24 ± 2.33# 5.58 ± 1.79# 5.06 ± 1.13# 3.89 ± 1.18 10.44 ± 3.91# 6.28 ± 2.19# 5.58 ± 1.81#
Lymphocytes (× 109/L) 1.67 ± 0.52 0.99 ± 0.41# 1.24 ± 0.39#* 1.48 ± 0.43# 1.70 ± 0.56 1.16 ± 0.38# 1.06 ± 0.41#* 1.50 ± 0.54#
CD4+T cells (× 109/L) 0.62 ± 0.25 0.32 ± 0.13# 0.51 ± 0.20#* 0.60 ± 0.23 0.62 ± 0.28 0.37 ± 0.20# 0.39 ± 0.21#* 0.59 ± 0.26
CD8+T cells (× 109/L) 0.47 ± 0.24 0.28 ± 0.13# 0.33 ± 0.13#* 0.41 ± 0.16 0.43 ± 0.19 0.27 ± 0.13# 0.26 ± 0.13#* 0.38 ± 0.22#
CD45RO+T cells (× 109/L) 0.52 ± 0.20 0.32 ± 0.14# 0.45 ± 0.15# 0.51 ± 0.17 0.55 ± 0.27 0.32 ± 0.17# 0.37 ± 0.18# 0.51 ± 0.27
NK cells (× 109/L) 0.29 ± 0.21 0.16 ± 0.11# 0.17 ± 0.10# 0.23 ± 0.13# 0.32 ± 0.22 0.18 ± 0.16# 0.14 ± 0.14# 0.25 ± 0.22#
CRP(mg/L) 11.93 ± 20.56 58.38 ± 32.51# 38.43 ± 34.12# 23.18 ± 25.51 8.87 ± 12.44 53.77 ± 31.16# 48.83 ± 35.78# 27.19 ± 25.25#
#P < 0.05, compared with preoperative levels;
*P < 0.05, compared between the two groups.
Especially, on POD 4, the count of lymphocytes, CD4+T cells and CD8+T cells were significantly higher in LCR group than OCR group (P < 0.05). The count of CD45RO+T cells in LCR group also had significant rise



















Many researches have confirmed that prognosis of can-
cers depends on invasion of tumors and immunoreaction
of bodies. Paholyuk [24] found that NK cells played an
important role in suppressing growth of colorectal can-
cers of stage II. Milašienė [25] reported that counts of
CD4+T cells, CD8+T cells and NK cells directly corre-
lated with long-term overall survivals of patients with
colorectal cancers and gastric cancers of stage III.
Hiki [12] reported that in laparoscopy there was gen-
erally less manipulation and exposure of the intestine
than in open surgery, with a further reduction in host
inflammatory responses. Our findings shew that mini-
mally invasive surgery resulted in a less pronounced
proinflammatory response to surgical trauma. Jung
[13] also got similar results in the research, who found
laparoscopic surgery got less influence on CRP than
open surgery.
Many researches have observed that there is a distinct
immunologic advantage to laparoscopic surgery [26-29].
Our findings confirmed better preserved cellular immune
responses in patients undergoing laparoscopic colorectal
resections. The counts of CD4+T cells, CD8+T cells,
CD45RO+T cells and NK cells were more in LCR group
than OCR group, especially on POD 4. This observation
was in agreement with the findings of Whelan [16], who
also observed better preserved cellular immune responses
in patients undergoing laparoscopic surgeries. Although
Figure 1 Summary of CRP between the two groups. On POD 1
and POD 4, the CRP levels were both significantly higher than the
preoperative levels in both two groups (P < 0.05). But on POD 7,
CRP descended to the preoperative level in LCR group (P > 0.05),
while CRP was still significantly higher than the preoperative level in
OCR group (P < 0.05).
Figure 2 Cell count of lymphocytes between the two groups.
On POD 1 and POD 7, in both two groups, the count of
lymphocytes significantly descended (P < 0.05), while there was no
difference between the two groups (P > 0.05). While on POD 4, the
count of lymphocytes was significantly higher in LCR group than
OCR group (P < 0.05).
Figure 3 Cell count of CD4+T cells between the two groups. On
POD 1, in both two groups, the count of CD4+T cells significantly
descended (P < 0.05), while there was no difference between the
two groups (P > 0.05). While on POD 4, the count of CD4+T cells
was significantly higher in LCR group than OCR group (P < 0.05).
On POD 7, the count of CD4+T cells rose to the preoperative level
in both two groups.
Figure 4 Cell count of CD8+T cells between the two groups. On
POD 1, in both two groups, the count of CD8+T cells significantly
descended (P < 0.05), while there was no difference between the two
groups (P > 0.05). While on POD 4, the count of CD8+T cells was
significantly higher in LCR group than OCR group (P < 0.05). On POD
7, the count of CD8+T cells rose to the preoperative level in LCR group,
while in OCR group, the count of CD8+T cells was still significantly
depressed compared with the preoperative level (P < 0.05).
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our findings were not completely comparable with the
researches from Wichmann [14], we found similar
change tendency of NK cells. Han [15] also reported that
laparoscopic resections got less influence on cellular
immune functions of the patients with colorectal cancers
of stage III. Peng [30] found the perioperative immune
response was less obvious after a laparoscopic procedure
compared with a conventional approach in patients with
renal cell carcinoma.
Compared with the previous research articles, our
study more comprehensively reflected the progress of
laparoscopic colorectal cancer radical resections and the
improvement of cellular immune protection nowadays
in Mainland of China.
There is a suggestion that cancers demonstrate a more
aggressive phenotype after open surgery, with the more
profound immunosuppression contributing to more
rapid cancer growth [31]. Milašienė [25] reported that
better cellular immunity correlated with higher post-
operative survival rates in patients. The long-term
effects of better preserved cellular immune responses
and its relationship with the prognosis of patients still
remain obscure. However, we can assume that our
observation of better preserved cellular immunity in
patients after laparoscopic colorectal surgeries has bene-
ficial effects on the prognosis of patients.
Conclusions
In conclusion, our study demonstrates that laparoscopic
colorectal resection gets less surgery stress and short-
term advantages compared with open resection. Also,
cellular immune respond appears to be less affected by
laparoscopic colorectal resection when compared with
open resection.
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